Chimeric Antigen Receptor (Car) T Cells As Therapeutic Interventions For Auto- And Allo-Immunity
Patent No. EP3858388 (titled "Chimeric Antigen Receptor (Car) T Cells As Therapeutic Interventions For Auto- And Allo-Immunity") was filed by Regents OF The University OF Minnesota on Sep 28, 2016. The application was issued on Jul 3, 2024.
Patent Summary
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3858388
- Application Number
- EP21154942A
- Filing Date
- Sep 28, 2016
- Status
- Granted And Under Opposition
- May 31, 2024
- Publication Date
- Jul 3, 2024
- External Links
- Slate, Register , Google Patents